Atorvastatin (as Calcium) 80mg Film Coated Tablet

SKU #: DMP-MD-203

Atorvastatin (as Calcium) 80mg Film Coated Tablet is a lipid-lowering medicine belonging to the statin class. It works by reducing cholesterol production in the liver, helping lower LDL cholesterol, total cholesterol, and triglycerides while helping reduce the risk of cardiovascular events in appropriate patients.

FDA Registration Number: DRP-7605

Low stock: only 1 left!

₱3,424.00₱2,397.0030% OFF

VAT-exempt

Pack size: 100 Tablets

Prescription required: Prescription medicines require a valid prescription and pharmacist approval before dispensing. Do not use this site to obtain medicines without appropriate medical supervision.

Dr. Med Pharmacy Quality Promise

Authentic medicines, pharmacist-backed service, and transparent product information.

Product details

Generic Name:Atorvastatin (as Calcium)

Category:Prescription Medicines

Brand:FULVAST

Strength:80mg

Dosage Form:Tablet

Indications

Used together with diet to reduce elevated total cholesterol, LDL cholesterol, apolipoprotein B, and triglycerides in patients with primary hypercholesterolemia, including familial hypercholesterolemia, or mixed hyperlipidemia when dietary and other non-drug measures are insufficient. It is also used for the prevention of cardiovascular events in patients at increased cardiovascular risk.

Contraindications

Hypersensitivity or allergy to atorvastatin or any component of the formulation.
Active liver disease.
Unexplained persistent elevations of serum transaminases exceeding three times the upper limit of normal.
Pregnancy.
Breastfeeding.
Women of childbearing potential who are not using appropriate contraception.
Concomitant treatment with glecaprevir/pibrentasvir.

Warnings and Precautions

Liver function should be assessed before treatment and when clinically indicated during therapy.
Use with caution in patients with a history of liver disease or substantial alcohol consumption.
Atorvastatin may cause muscle-related adverse effects, including myopathy and, rarely, rhabdomyolysis. Patients should promptly report unexplained muscle pain, tenderness, weakness, or cramps.
The risk of muscle injury may be increased by certain medicines and in patients with factors such as renal impairment, hypothyroidism, or a previous history of statin- or fibrate-associated muscle toxicity.
Rare cases of immune-mediated necrotizing myopathy have been reported during or after statin therapy.
Inform the healthcare professional about all medicines being taken because atorvastatin may interact with certain antivirals, antibiotics, antifungals, immunosuppressants, and other lipid-lowering medicines.
Treatment should be used together with appropriate dietary and lifestyle measures as advised by a healthcare professional.
Do not discontinue or change the prescribed dose without consulting a healthcare professional.